In the U.S., please contact us by phone at (224) 667-6100 or email.
View additional global locations and contacts on our contact page.
About Abbott
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio includes many life-changing technologies spanning the spectrum of healthcare:
- Find more info.
- Read the latest news.
- Check financials.
- Keep up with our social responsibility.
- To learn more about Abbott careers, visit our career page.
- If you are a student interested in our career development programs, click here.
Our corporate headquarters is in Lake County, Illinois, at Abbott Park, a suburb 40 miles north of Chicago, IL, U.S.
Abbott also has many locations throughout the United States and the world. See our global locations and contacts for a full list.
Yes, you can find us on X at @AbbottGlobal and @AbbottNews.
Or on Facebook at www.facebook.com/Abbott.
Abbott products
To view a selection of products that people use every day, visit the Abbott product list page.
To browse and purchase Abbott products, visit the Abbott Store.
Learn more about Abbott's approach to tackling the Coronavirus, the company's range of COVID-19 tests, including rapid testing with ID NOW and BinaxNOW™ COVID-19 Ag Card, as well as antibody testing.
- For more information, visit our COVID-19 FAQ page.
Where can I get more information or order FreeStyle Libre?
For information on FreeStyle Libre, our continuous glucose monitoring system:
- Visit the FreeStyle Libre Website.
- Learn about the FreeStyle Libre 14 day system.
- Learn about the FreeStyle Libre 2 system.
- Please see our contact information.
- For additional information, visit the FreeStyle Libre support page
- Visit the Pedialyte Website.
- Find where to buy Pedialyte.
- Find the right phone number, or send us an email if you would prefer.
- Visit the MitraClip Transcatheter Mitral Valve Repair System Website.
- Learn more about the MitraClip Transcatheter Mitral Valve Repair System.
- Find the right phone number, or send us an email if you would prefer.
Nutrition business separation
Abbott has announced a plan to separate our global Nutrition business into an independent, publicly traded company by the end of 2027.
That means the Nutrition business — with brands including Ensure, Similac, Pedialyte, PediaSure and Glucerna — would operate as its own company.
Abbott shareholders would own shares in both Abbott and the new Nutrition company after the separation is complete.
Yes. The new company will continue to make the products and brands you are familiar with, including Ensure, Similac, Pedialyte, PediaSure and Glucerna.
They will continue to be available at retailers and where you normally find them.
Abbott expects to complete the transaction by the end of 2027, subject to customary conditions, including regulatory approvals and final approval by the Abbott Board of Directors.
The Nutrition business will continue to operate as part of Abbott until the separation process is complete.
Abbott has a successful history of shaping the company through internal and external actions that deliver on evolving growth opportunities.
We regularly examine the makeup of the company, and it is clear that the Nutrition business has a unique opportunity to capitalize on consumer preferences and trends in healthy nutrition. As an independent company, it will be better positioned to focus its resources more strategically across innovation, commercial activities and key initiatives that advance performance and long-term value creation. At the same time, Abbott will focus on its core higher-growth, innovation-driven portfolio of medical devices, biowearables, diagnostics and established pharmaceuticals, which has compelling opportunities to expand health impact for people around the world.
With different investment identities and requirements, growth profiles and innovation cycles, both companies will benefit from resource and capital allocation strategies aligned to their distinct business models.
The new Nutrition company will be a global leader in healthy nutrition with approximately $8.5 billion in annual sales, about 16,000 employees and 14 manufacturing sites. It will have a portfolio of household brands across infant, pediatric, medical and adult nutrition, including Similac, PediaSure, Pedialyte, Glucerna and Ensure. The new Nutrition company will be differentiated by its product offerings, which are backed by evidence-based scientific research and healthcare professional recommendation, as well as its presence and scale across both developed and fast-growing emerging markets.
Abbott remains one of the largest, fastest growing and most diversified healthcare companies with unique breadth and scale. It will have market-leading positions in cardiovascular and neuromodulation devices; biowearables; laboratory, point-of-care and cancer diagnostics; and established medicines. This portfolio helps people stay and get healthy, manage chronic conditions and enable informed and earlier clinical decision making.